Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cornerstone and Lupin join to develop anti-infective
In the agreement, Cornerstone has the rights to sell and market the prescription drug in the US, upon FDA approval. Lupin will receive, in aggregate, an amount of
In the agreement, Cornerstone has the rights to sell and market the prescription drug in the US, upon FDA approval. Lupin will receive, in aggregate, an amount of
RhuDex is an orally administered small molecule principally indicated for the treatment of rheumatoid arthritis (RA). RhuDex offers a novel approach in the treatment of RA by blocking
A patent appeals board had ruled in favor of Affymetrix, as did the U.S. District Court for the Northern District of California. But the U.S. Court of Appeals
Diovan is now indicated as a potentially life-saving therapy for the more than 750,000 people in the EU who are at risk of a recurrent heart attack or
This is one of several granted and pending patents that protect the company’s ownership of the 5T4 tumor antigen. The granted patent covers immunotherapy products directed against 5T4
The FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) reviewed a print advertisement for Zoloft (sertraline HCl) tablets published in the New York Times magazine last October.
The findings came from three separate studies involving glioblastoma multiforme (GBM), the most common form of brain tumor and the least curable of all human cancers. The first
In fact, when the two are combined, the study showed, the amount of medication required to achieve the same results as use of medication alone can be reduced
In May 2004, SkyePharma announced that it had granted First Horizon exclusive US marketing and distribution rights for a cardiovascular product (now identified as fenofibrate IDD-P). Under this
Picoplatin (NX 473) is a next-generation intravenous platinum chemotherapeutic agent specifically designed to improve on the safety and efficacy of existing platinum therapeutics for cancer. The company also